Targeting the HSP60/p53 Axis with Extracellular Vesicle-Delivered siRNA Reprograms Glycolysis in Prostate Cancer
Year: 2025
Type: article
Abstract: demonstrate precision therapeutic potential with robust efficacy and safety, offering a novel approach for targeted therapy in PCa.
DOI: 10.7150/ijbs.120760
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,337
OpenAlex ID: W4417068324
